4-butyrolactone has been researched along with Cancer of Rectum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach Knudsen, KE; Herzig, KH; Klintrup, K; Mäkelä, J; Mäkinen, MJ; Mutt, SJ; Nørskov, NP; Sirniö, P; Tuomisto, A; Väyrynen, JP | 1 |
| Bach Knudsen, KE; Christensen, J; Egeberg, R; Johnsen, NF; Loft, S; Olsen, A; Overvad, K; Thomsen, BL; Tjønneland, A | 1 |
2 other study(ies) available for 4-butyrolactone and Cancer of Rectum
| Article | Year |
|---|---|
Serum enterolactone concentrations are low in colon but not in rectal cancer patients.
Topics: 4-Butyrolactone; Aged; Case-Control Studies; Colon; Colonic Neoplasms; Diet, Western; Dietary Fiber; Feeding Behavior; Female; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Intestinal Mucosa; Lignans; Male; Middle Aged; Rectal Neoplasms; Rectum; Risk Factors | 2019 |
Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and women.
Topics: 4-Butyrolactone; Case-Control Studies; Cohort Studies; Colonic Neoplasms; Denmark; Feeding Behavior; Female; Humans; Life Style; Lignans; Male; Middle Aged; Phytoestrogens; Rectal Neoplasms; Risk Factors | 2010 |